STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
2
13F, latest reported quarter
What the filings say about HAO
Insiders, 180 days
+$800.0K net bought
1 buyer
Haoxi Health Technology insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Haoxi Health Technology Ltd insiders bought a net $800.0K of stock across 1 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 98.3% of the 40,690,800 shares held after it.
No other insider bought within 30 days.
2 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & Chairman Fan Zhen bought about $800.0K of HAO on May 19, 2026, the largest insider purchase at the company on our record; 2 funds added in the latest 13F quarter.
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HAO planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $800.0K bought by insiders over 180 days, 2 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Single quarter
Debt to equity
0.03x
long-term 2025-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity HAO
FY Jun 2026
0.03x
FY Jun 2025
0.03x
FY Jun 2024
0.10x
FY Jun 2023
0.18x
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
needs four quarters of operating cash flow
Cash flow to debt HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing HAO
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HAO ranks highest on growth (91st percentile) and financial health (85th), and lowest on risk and compliance (3rd), among Media peers.
Financial health
85
Inputs
Debt to equity0.03x · 85 pct, sector of 66
Cash flow to debtneeds four quarters of operating cash flow
Growth
91
Inputs
Revenue growth, YoY+67.1% · 91 pct, sector of 100
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
73
Inputs
Net Form 4 buying (codes P and S), 180d$800K · 88 pct, sector of 52
Insider buyers, 180d1 · 57 pct, sector of 52
Risk and compliance
3
Inputs
Short interest, % of float+25.9% · 3 pct, sector of 101
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Profitability, Institutional and government, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HAO filings, in plain words
Are Haoxi Health Technology insiders buying or selling HAO?
In the 180 days to 2026-10-27, Haoxi Health Technology insiders were net buyers, a net $800.0K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-27, Haoxi Health Technology insiders were net buyers of HAO, a net $800.0K across purchases and sales reported on Form 4 by 1 buyer. Most of that figure, $800.0K, came from a holder of 10% or more rather than an officer or director. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.